FindMyKOL
Clinical trialNCT02756286CompletedObservational

Neurophysiological Attention Test (NAT) for Objective Assessment of Adult ADHD

NCT02756286 is an observational study sponsored by Think Now Incorporated. As of 21 Nov 2026, it is completed. It studies Attention Deficit Hyperactivity Disorder. The registry lists an enrollment of 258 participants at 3 sites in 1 country. The registry lists a start date of 1 Jan 2017 and a primary completion date of 1 Jun 2018.

SponsorThink Now IncorporatedEnrollment258Attention Deficit Hyperactivity Disorder
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02756286
FieldValue
Registry IDNCT02756286
StatusCompleted
Study typeObservational study
Lead sponsorThink Now Incorporated
Enrollment258
Registered sites3
Countries1
ConditionsAttention Deficit Hyperactivity Disorder
Start1 Jan 2017
Primary completion1 Jun 2018
Study completion5 Jul 2018
Last update posted19 Sept 2018

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to refine a new assessment tool for Attention Deficit/Hyperactivity Disorder (ADHD) and then to test its validity (i.e. ability to discriminate between individuals with ADHD and healthy controls.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States2 sites
  • University of California Berkeley

    Berkeley

  • Ucla Semel Institute

    Los Angeles

Oregon, United States1 site
  • Oregon Health & Science University

    Portland

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregon: 1 siteOR1IdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 2 sitesCA2NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT02756286

Each answer restates registry values shown on this page.

What is NCT02756286?

NCT02756286 is an observational study sponsored by Think Now Incorporated. It studies Attention Deficit Hyperactivity Disorder.

Who leads NCT02756286?

The registry names Gregory V Simpson, Ph.D. (principal investigator, Think Now, Inc.) as the overall official.

Where does NCT02756286 run?

The registry lists 3 sites in 1 country. Every site with a stated country is in one country: United States.

When did NCT02756286 end?

The registry lists a primary completion date of 1 Jun 2018 and a study completion date of 5 Jul 2018. The sponsor last updated the record on 19 Sept 2018.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.